The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
read page 14 .................. of the description .. OMG
https://register.epo.org/application?documentId=E47EAZPI5402DSU&number=EP17194252&lng=en&npl=false
some of the epitopes can be used for "suppression" .....
nightmare ... upgraded my phone to Voice over internet ... BT cut of the old line without saying .. so just had to study the new phone ... smart kit the new phone is awesome ... and worked instantly including a very flash clock displayed
link ...= comment
trying to catch up on the BBC news ref statements
those predictions look very real ....
and if true ......... especially ref the antibodies ... Puts Scancell in an unbelievable position because we are building a vaccine today ... not based on just the genome of the virus as it was in January
again show the link Bermuda ... if you asking for specifics .. and i will have a read ....
but also read this
https://www.nature.com/articles/nature14426?page=7
dated 2015
""The CD4+ T cells are of particular interest"""", as coadministration of CD4+ T cells to TCR-engineered adoptively administered T cells has been shown to enhance tumor infiltration of CD8+ T cells and to prevent their exhaustion """
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485745/
he likes CD4 ....
ATB
i would describe it as the Zebra crossing .... patent
it does not matter how or why you entered the pedestrian entered that zone .............. but if you as a driver hit somebody on it .. you are at fault
the patent is the zebra crossing .....
i will repeat ......... ALL the patents granted to be granted .... protect the fundamental Consequence of Moditope
The ........... Generated TCR
if the TCR is not protected .............. we have no patent protection at all
Biontech would not be collaborating ... instead they would build and MRNA moditope vaccine and clone t cells from that
pretty sure
even if you discovered a new sequence ... ie peptide on the cancer .. you would still fall under the patent .. because to get it to work you need to citrullinate it ... ie that modification
Land Grab
last attempt .......
All the patents of moditope protect the TCR ................. because the TCR is the consequence of the patent ...
the patent is written in a way that protects us from others using any form of the sequence using nucleic acid or peptide etc
in previous debates on this very subject i emailed the boss with a very specific question
Ref the current published patents for moditope
1/ the activated TCR's generated by exposure to the modi1 peptides ... ie is the current information
that has been put out in RNS regarding BioNtech modi 1 epitopes, is that covered under the existing published patents or divisional patents
effectively "protecting " the TCR 's generated
reply
Yes